VenoStent, Inc.
Shape memory polymer external vein wrap (SelfWrap) for peripheral artery bypass grafting
- Sector
- Medtech
- Headquarters
- Nashville, TN
- Founded
- 2017
- Latest Form D
- $10M, May 2026
- Total capital
- $34.7M
- Federal grants
- $5.5M
- 7 awards · 2018–2026
- Rank in peer group#103 of 538
- Private capital raised
- $29.2M
- 6 Form D · last May 2026
- 6 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 4 pending · first 2025
- Rank in peer group#190 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS$1.2M
- Private capital raisedForm D · SEC · 6th filing$10M
- Federal grantHealth and Human S · Phase II · TABA for SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS$50K
- Federal grantHealth and Human S · Phase II · SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS$1.2M
- Federal grantHealth and Human S · Phase II · SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS$1.2M
- Private capital raisedForm D · SEC · 5th filing$16.1M
- Private capital raisedForm D · SEC · 4th filing$2.2M
- Private capital raisedForm D · SEC · 3rd filing$515K
- Private capital raisedForm D · SEC · 2nd filing$264K
- Private capital raisedForm D · SEC · 1st filing$70K
Show 3 earlier federal awards
- Federal grantHealth and Human S · Phase I · Biodegradability and Biocompatibility of a Shape Memory Polymer Wrap to Improve Saphenous Vein Graft Patency in Peripheral and Coronary Artery Bypass Grafting Surgeries$300K
- Federal grantNSF · Phase II · SBIR Phase II: Hemodynamic Optimization and Preclinical Assessment of a Shape Memory Polymer Wrap to Reduce Hemodialysis Access Site Failures$1.3M
- Federal grantNSF · Phase I · STTR Phase I: Hemodynamic Effects Inform Design of an External Stent to Reduce Dialysis Access Failures$224K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#103 · top 19%
- Granted patents#190 · top 35%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Timothy BoireResearcherExecutive Officer, DirectorLinked by 2 patents · $1.8M in grants as PI
- Geoffrey LucksExecutive Officer, DirectorNamed in SEC Form D filings
- Jim MonsorDirectorNamed in SEC Form D filings
- Joel WhitleyDirectorNamed in SEC Form D filings
- Kulika WeizmanDirectorNamed in SEC Form D filings
- Robert CrutchfieldDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 6- PendingPolymeric Vascular Grafts Which Induce Neovascularization With Mild To Minimal Inflammation And Promotion Of Fibrovascular TissueUSPTOApplication 19400755
- PendingAdditive Manufacturing Of Vinyl, Photocrosslinkable PolymersUSPTOApplication 19408849
- GrantedAdditive Manufacturing Of Vinyl, Photocrosslinkable PolymersUSPTOUS 12,544,486
Show all 6 patent records
- Polymeric Vascular Grafts Which Induce Neovascularization With Mild To Minimal Inflammation And Promotion Of Fibrovascular TissueApr 9, 2026 · Application 19400755Pending
- Additive Manufacturing Of Vinyl, Photocrosslinkable PolymersMar 26, 2026 · Application 19408849Pending
- Additive Manufacturing Of Vinyl, Photocrosslinkable PolymersFeb 10, 2026 · US 12,544,486Granted
- Polymeric Vascular Grafts Which Induce Neovascularization With Mild To Minimal Inflammation And Promotion Of Fibrovascular TissueNov 25, 2025 · US 12,478,720Granted
- Additive Manufacturing Of Vinyl, Photocrosslinkable PolymersApplication PCTUS2020043159Pending
- Additive Manufacturing Of Vinyl, Photocrosslinkable PolymersApplication 62877066Pending
Related companies, and why
- VenoStent, IncShares a founder: TIMOTHY BOIRE
- RAMONA OPTICS, INC.Similar federal contract value in Medtech · null in contracts
- REQUISITE BIOMEDICAL, LLCSimilar federal contract value in Medtech · null in contracts
- SONOVANCE, INC.Similar federal contract value in Medtech · null in contracts
- APTUS BIOSCIENCES LLCSimilar federal contract value in Medtech · null in contracts
- ISONO HEALTH, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .